No results found.

Screeners (33,980)

Signal Glossary

DTL Breach Warning
Price has pushed through the Demand Threshold Line (those orange bars). It flags price vulnerability at/through that boundary for the current week.
Smart Money Buy
A โ€œsmart moneyโ€ star printed on the chart. It marks concentrated, high-quality buying activity often seen ahead of stronger moves. (We only log it when the star appears.)
Investor Buy
An โ€œinvestor buyโ€ star printed on the chart. It reflects broader, more general momentum by investors. (Again, only logged when the star appears.)
Accumulation
A green bar (often within a negative market cycle). Each green bar signals steady, systematic buying/absorbing of supply.
Distribution
The counterpart to accumulation. It marks persistent selling/handing off of shares - supply is dominating and pressure is to the downside.
Ribbon Change
The ribbon flips color (red โ†” green). We log the first bar of a new segment, which signals a regime shift in the underlying indicator.
Threshold Breach (Buy)
The composite indicator crosses down through the dynamic Bottom threshold. Itโ€™s a โ€œbuy-sideโ€ extreme that often precedes an upward move.
Threshold Breach (Sell)
The composite indicator crosses up through the dynamic Top threshold. Itโ€™s a โ€œsell-sideโ€ extreme that often precedes a downward move.
Baseline Crossover
The tracked metric crosses its baseline (typically zero). Crossing up suggests improving conditions; crossing down suggests deterioration.
Demand โˆ’1 Crossover
Price crosses up through the โ€œโˆ’1 demandโ€ reference level. It signals a possible early improvement in demand conditions after a weak phase.
Valuation Change
A change in our valuation classification (e.g., from overvalued to fairly valued). It captures a material update to the valuation state for screening.
Info Update
A notable informational event (e.g., earnings/guidance/corporate update) that we tag for the screener so you can filter around fresh developments.
ML Turned Positive
The Magic Line (smoothed activity) crosses above zero and turns positive. It indicates a shift toward constructive momentum/pressure.
ML Turned Negative
The Magic Line crosses below zero and turns negative. It indicates a shift toward weakening momentum/pressure.

Nasdaq

(NASDAQ)
ACIC
American Coastal Insurance Corporation
?
Accumulation ?
C2 F1 O1 R2
?
Moderately Overvalued
Target: 10.53 ?
ACIW
ACI Worldwide, Inc.
?
Accumulation ?
C3 F2 O2 R1
?
Moderately Overvalued
Target: 40.24 ?
AMPH
Amphastar Pharmaceuticals, Inc.
?
Accumulation ?
C1 F1 O3 R1
?
Extremely Undervalued
Positive ?
AMRX
Amneal Pharmaceuticals, Inc.
?
Accumulation ?
C2 F2 O2 R1
?
Significantly Undervalued
Target: 14.20 ?
AMSC
American Superconductor Corporation
?
Accumulation ?
C2 F1 O3 R1
?
Extremely Overvalued
Negative ?
AOK
iShares Core 30/70 Conservative Allocation ETF
?
Accumulation ?
No valuation data
?
โ€”
โ€”
ARTW
Art's-Way Manufacturing Co., Inc.
?
Accumulation ?
C1 F2 R2
?
Moderately Undervalued
Target: 2.60 ?
ATYR
aTyr Pharma, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
AVPT
AvePoint, Inc.
?
Accumulation ?
C3 F2 O3 R2
?
Deeply Overvalued
Negative ?
AWRE
Aware, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BDTX
Black Diamond Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BLDE
Strata Critical Medical, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
BTBT
Bit Digital, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CAMT
Camtek Ltd.
?
Accumulation ?
C3 F3 O3 R1
?
Significantly Overvalued
Target: 63.00 ?
CARG
CarGurus, Inc.
?
Accumulation ?
C3 F3 O3 R1
?
Significantly Undervalued
Target: 38.80 ?
CASI
CASI Pharmaceuticals, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CENTA
Central Garden & Pet Company
?
Accumulation ?
C2 F1 O3 R1
?
Moderately Undervalued
Target: 31.39 ?
CRVL
CorVel Corporation
?
Accumulation ?
C3 F2 O2 R2
?
Significantly Overvalued
Target: 40.40 ?
CRVS
Corvus Pharmaceuticals, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
CTSH
Cognizant Technology Solutions Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
DMAC
DiaMedica Therapeutics Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
EXPE
Expedia Group, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
FFIV
F5, Inc.
?
Accumulation ?
?
Significantly Overvalued
Target: 180.77 ?
FORM
FormFactor, Inc.
?
Accumulation ?
C1 O1 R2
?
Significantly Overvalued
Target: 33.40 ?
FORTY
Formula Systems (1985) Ltd.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
FSV
FirstService Corporation
?
Accumulation ?
C3 F1 O2 R1
?
Significantly Overvalued
Target: 112.60 ?
GDRX
GoodRx Holdings, Inc.
?
Accumulation ?
C1 O3 R1
?
Extremely Undervalued
Positive ?
GEN
Gen Digital Inc.
?
Accumulation ?
C3 F2 O1 R1
?
Moderately Undervalued
Target: 28.13 ?
GOOGL
Alphabet Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
HLMN
Hillman Solutions Corp.
?
Accumulation ?
C2 F2 O1 R1
?
Significantly Undervalued
Target: 11.40 ?
KALV
KalVista Pharmaceuticals, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
MCVT
SUI Group Holdings Limited
?
Accumulation ?
No valuation data
?
โ€”
โ€”
MDXG
MiMedx Group, Inc.
?
Accumulation ?
C3 F3 O3 R1
?
Moderately Overvalued
Target: 6.20 ?
MKSI
MKS Inc.
?
Accumulation ?
C2 F2 O3 R1
?
Significantly Overvalued
Target: 107.02 ?
MLKN
MillerKnoll, Inc.
?
Accumulation ?
C2 F1 O2 R1
?
Significantly Undervalued
Target: 17.02 ?
OPEN
Opendoor Technologies Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
PARAA
Paramount Skydance Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
POET
POET Technologies Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
PPC
Pilgrim's Pride Corporation
?
Accumulation ?
C2 F1 O1 R1
?
Moderately Overvalued
Target: 32.31 ?
RIGL
Rigel Pharmaceuticals, Inc.
?
Accumulation ?
C3 F3 O3 R1
?
Extremely Overvalued
Negative ?
RZLT
Rezolute, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
SBLK
Star Bulk Carriers Corp.
?
Accumulation ?
C1 O2 R2
?
Extremely Undervalued
Positive ?
SGRY
Surgery Partners, Inc.
?
Accumulation ?
C2 F1 O3 R1
?
Significantly Overvalued
Target: 16.04 ?
SITM
SiTime Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”
SKYW
SkyWest, Inc.
?
Accumulation ?
C2 F2 O1 R1
?
Moderately Overvalued
Target: 78.63 ?
SLDB
Solid Biosciences Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
STOK
Stoke Therapeutics, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
TER
Teradyne, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
TFIN
Triumph Financial, Inc.
?
Accumulation ?
No valuation data
?
โ€”
โ€”
TSAT
Telesat Corporation
?
Accumulation ?
No valuation data
?
โ€”
โ€”